awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51715018-6EBF5485-E0D1-4328-82E6-DBBD97F3E898
Q51715018-6EBF5485-E0D1-4328-82E6-DBBD97F3E898
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51715018-6EBF5485-E0D1-4328-82E6-DBBD97F3E898
Biosimilar and innovator anti-Tumour Necrosis Factor (TNF) or lymphocyte trafficking blockade: Which one to select?
P2860
Q51715018-6EBF5485-E0D1-4328-82E6-DBBD97F3E898
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51715018-6EBF5485-E0D1-4328-82E6-DBBD97F3E898
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a606f7373b676491b0228c490f57fb9be6b6337a
P2860
Vedolizumab as induction and maintenance therapy for Crohn's disease.